ISPC - iSpecimen: High Growth Marketplace At A Discount
- Each year, researchers face substantial challenges trying to get the right specimens for research from a fragmented network of biobanks.
- iSpecimen's platform connects these 2 groups, saving substantial time and money for researchers as well as ensuring compliance.
- The company has the opportunity to disrupt the massive $3-4bil specimen procurement market and generate additional revenue from the patient data they own.
- Profitability is quickly arriving and the company has substantial cash to further invest in growth after its IPO.
For further details see:
iSpecimen: High Growth Marketplace At A Discount